1. Home
  2. ADXN

as 05-22-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Founded: 2002 Country:
Switzerland
Switzerland
Employees: N/A City: N/A
Market Cap: 9.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 20.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.15 EPS Growth: N/A
52 Week Low/High: $5.00 - $27.90 Next Earning Date: 05-28-2024
Revenue: $1,960,796 Revenue Growth: 13.99%
Revenue Growth (this year): 95.07% Revenue Growth (next year): 241.27%

Share on Social Networks: